Today's New Buy Pick - FlexShopper, Inc. (FPAY)

3 “Grossly Undervalued” Energy Stocks That Could Be About To Rally Higher One expert says these 3 energy stocks could see substantial upside ahead. Energy might be the S&P 500’s worst performing sector this year, but now may be the time to consider energy stocks. The [XLE S&P 500 Energy Sector SPDR]( is down more than -20% from its highs reached late last year, and is technically in a bear market. And while the ETF has gained nearly 4% year-to-date, that return is a far cry from the S&P 500’s 25% rise.  [Read More]( [Tap these 65 "Inbox Money" Secrets...]( 65 "Mailbox Money" secrets ANYONE can collect! Everyone can use extra cash these days... And that's exactly why income expert - Neil George - is giving away his latest book... Titled Income For Life, this massive book profiles 65 unique streams of income, capable of generating an extra $237...$1,245...or even $10,312 each and every month. (ad) [Click here to learn how to reserve claim your FREE copy today!](  [[Special Gift] #1 Retirement Playbook For IRA/401K Account Holders.]( If you want to keep what's in your IRA/401k then you NEED to read this. The next market crash will not discriminate when it comes to individual mutual funds. They are ALL waiting to be slammed with major losses. Learn why gold and silver are poised for massive gains and the IRS 'loophole' that allow you to transfer your IRA/401K into gold. (ad) [This #1 Retirement Playbook could SAVE your Retirement...](  Mersana Therapeutics, Inc. (MRSN) Is Up 95% This Month. Is This Just The Beginning? The current rank for Mersana Therapeutics Inc is 86, this means that MRSN is out performing 86% of its peers. Stocks that have a rank of 80 or better, with support of all other analyses shown here, tend to advance the trend. The current Annual EPS Growth for Mersana Therapeutics Inc is 53.33% which is greater than the 30% average found is strong trending, fundamentally sound companies. The current Quarterly EPS Growth for Mersana Therapeutics Inc is 2.78% which is less than the 25% average found is strong trending stocks even during or before huge price moves. The current Quarterly Sales Growth for Mersana Therapeutics Inc is 317.82% which is greater than the 25% average found is strong trending stocks. [Read More](  [Download Your Free Copy]( Free book reveals 5 secret trading strategies to win every day in the market. (ad) [Click here.]( Featured Stock [FlexShopper, Inc. (FPAY) – Buy Target – $1.82 or better]( Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not amenable to treat with traditional ADC-based therapies. Its lead product candidate is XMT-1536, a Dolaflexin ADC targeting NaPi2b that is in Phase I clinical trial for the treatment of patients with ovarian cancer, non small cell lung cancer, and other orphan indications. Other Top Stories [The Strongest DOW Stocks To Buy]( [Michigan, Illinois set to usher in recreational pot sales](   [Holiday stress: Amazon, others under gun for 1-day delivery](  [Guess, Box post gains while Deere, Boeing tumble](    Sponsor [Successful Angel Investor Reveals Next #1 Tech Stock]( Legendary investor Jeff Brown believes 10% of the world's population will be buying this new technology by the end of the year... (ad) [Find out his #1 "slam-dunk" tech stock for 2020. Click here to learn more.](  Trend Following Picks [(MLSS) Buy Target – $1.35 or better]( [(VERU) Buy Target – $2.22 or better]( [(JCS) Buy Target $7.40 or better]( [(JE) – Buy Target – $2.80 or better]( [(AVDL) Buy Target – $5.75 or better]( [All Picks]( Reversal Picks [(PIRS) Buy Target $4.05 Sell Target $4.79]( [(MGTX) Buy Target $17.29  Sell Target $19.46]( [(DQ) Buy Target $42.51 Sell Target $46.71]( [All Picks](  Already subscribed to our premium service? [Click here to Login]( Not a TradersPro subscriber yet? [Try It Now -  Limited Time Offer](                                --------------------------------------------------------------- This email was sent to {EMAIL} by Investiv, LLC 265 N. Main | Ste. D #283 | Kaysville | UT | 84037 [Forward to a friend]( | [Unsubscribe]( or [Mange which emails you get from TradersPro]( Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses. Hypothetical Results Are Reported Results and examples used in the Company’s advertisements, books, videos, websites, and other media—including on the Site and the Network—are, in some cases, based on hypothetical (simulated) trades. Plainly speaking, these trades were not actually executed. Hypothetical performance results have certain limitations. Unlike an actual performance record, hypothetical results do not represent actual trading. Also, since the trades have not been executed, the hypothetical results may have under-or-over compensation for the impact, if any, of certain market factors, such as lack of liquidity. Hypothetical trading programs generally are also subject to the fact that they are designed with the benefit of hindsight. Hypothetical results also do not account for commissions or slippage. The Company’s simulations assume purchase and sale prices believed to be attainable. Yet traders are going to be getting into trades at different times and using various exit approaches, which may result in different pricing and outcomes. You may or may not receive the best available price on the purchase or the sale of a position in actual trading. Information provided by the Company is not investment advice. The Company is not a registered investment adviser, stock broker, or brokerage. You agree that the Company does not represent, warrant, or take responsibility that any account will or is likely to achieve profit or losses similar to those shown. Examples published by the Company are selected for illustrative purposes only. They are not typical and do not represent the typical results of all stocks within the Company’s software or its individual scans and searches. No independent party has audited any hypothetical performance contained at this Web site, nor has any independent party undertaken to confirm that they reflect the trading method under the assumptions or conditions specified. Offers Disinterested Commentary and Analysis The Company does not receive any form of payment or other compensation for publishing information, news, research, or any other material concerning specific securities on the Network that is intended to affect or influence the value of securities. The Company, and its personnel, do not engage in front-running of recommendations and do not trade against one’s own recommendations. The Company and its management may benefit from an increase or decrease in the share prices of the profiled companies, and/or may have other actual or potential conflicts of interest. If a particular security featured in a newsletter publication is concurrently owned by the Company in its corporate brokerage account, or in any of the individual accounts of the Company’s principals or analysts / writers, that fact will be disclosed. The Company, its principals, analysts and writers may choose to purchase a security or derivative featured in one of its newsletter publications, but typically will wait three (3) trading days from the date of publication before initiating said purchase. [Disclaimers, Terms & Conditions]( | [Privacy Policy]( Copyright © 2019